Aarkstore Enterprise Horizon Pharma, Inc - Product Pipeline Review - Q4 2010

Aarkstore announce a new report "Horizon Pharma

, Inc. - Product Pipeline Review - Q4 2010" through its vast collection of market research report.

Horizon Pharma, Inc. - Product Pipeline Review - Q4 2010 provides data on the companys research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from proprietary databases, Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together.

Scope

- Horizon Pharma, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.

- Review of current pipeline of Horizon Pharma, Inc. human therapeutic division.

- Overview of pipeline therapeutics across various therapy areas.

- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

- Product profiles for late stage and clinical stage products of Horizon Pharma, Inc. with complete description of the products developmental history, mechanism of action, therapeutic class, target and major milestones.

- Recent updates of the Horizon Pharma, Inc.s pipeline in the last quarter.

- Key discontinued and dormant projects.

- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Horizon Pharma, Inc.s strategic position with total access to detailed information on its product pipeline.

- Assess the growth potential of Horizon Pharma, Inc. in its therapy areas of focus.

- Identify new drug targets and therapeutic classes in the Horizon Pharma, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.

- Exploit collaboration and partnership opportunities with Horizon Pharma, Inc..

- Avoid Intellectual Property Rights related issues.

- Explore the dormant and discontinued projects of Horizon Pharma, Inc. and identify potential opportunities in those areas.

For more information, please visit:

http://www.aarkstore.com/reports/Horizon-Pharma-Inc-Product-Pipeline-Review-Q4-2010-86472.html

Or email us at press@aarkstore.com or call +919272852585

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise Ampio Pharmaceuticals, Inc - Product Pipeline Review - Q4 2010 Moncler Is Definitely The Best Choice For Us Serial Interface Lcd Module Lcd Panel Production Process Revealed Private Label Rights: Your Licence to Sell Other People's Products As Your Own Private Label Rights as a Shortcut For Creating Your Own Products Aarkstore Enterprise Zellerx - Product Pipeline Review - Q4 2010 Product Review: Standard 111 Paper Drill Leather Jackets Were Once Fashionably Black, But Other Colours Are On The Rise Product Review: Handy-Drill Paper Drill Address Book: Impress You Clients With Your Effortlessness Of Contacts Collagen Injections Against Natural Products Prom Night Dresses, Be You Aarkstore Enterprise Angelini Pharmaceuticals - Product Pipeline Review - Q4 2010